Genenta Science S.p.A. (GNTA)
NASDAQ: GNTA · Real-Time Price · USD
2.170
-0.010 (-0.46%)
Nov 14, 2025, 4:00 PM EST - Market closed
Genenta Science Market Cap
Genenta Science has a market cap or net worth of $41.55 million as of November 14, 2025. Its market cap has decreased by -56.52% in one year.
Market Cap
41.55M
Enterprise Value
29.67M
1-Year Change
-56.52%
Ranking
Category
Stock Price
$2.17
Market Cap Chart
Since the IPO on December 15, 2021, Genenta Science's market cap has decreased from $208.76M to $41.55M, a decrease of -80.10%. That is a compound annual growth rate of -33.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 14, 2025 | 41.55M | -47.78% |
| Dec 31, 2024 | 79.56M | -11.77% |
| Dec 29, 2023 | 90.17M | -10.00% |
| Dec 30, 2022 | 100.19M | -49.56% |
| Dec 31, 2021 | 198.63M | -4.85% |
| Dec 15, 2021 | 208.76M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 918.02B |
| Johnson & Johnson | 472.05B |
| AbbVie | 410.67B |
| UnitedHealth Group | 291.55B |
| AstraZeneca | 276.16B |
| Novartis AG | 252.58B |
| Merck & Co. | 230.63B |
| Abbott Laboratories | 227.08B |